EMEA-002940-PIP02-21

Key facts

Active substance
Molnupiravir
Therapeutic area
Infectious diseases
Decision number
P/0553/2021
PIP number
EMEA-002940-PIP02-21
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate dosage form
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

E-mail: pip.information@merck.com
Country: Belgium
Tel. + 33 180 464 738

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating